⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
STING Inhibitors (H-151)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-14 — MA-5 attenuates disease-associated transcriptomic aging and pathological microglial states in Gaucher disease.: cross-connection with mitochonic-acid-5: MA-5’s benefit in Gaucher models depends on quieting STING-driven microglial inflammation, overlapping with the therapeutic hypothesis behind direct STING inhibitors like H-151. (novelty: 3)
- 2026-05-15 — Jintiange ameliorates age-related sarcopenia by inhibiting the cGAS-STING signaling pathway via maintaining mitochondrial homeostasis.: cross-connection with jintiange: Jintiange’s proposed mechanism converges on cGAS–STING suppression, linking a TCM sarcopenia candidate to the STING-inhibitor target class. (novelty: 3)
- 2026-09-01 — NADMetabolic Reprogramming Drives CD8T Cells Senescence and Exacerbates Ulcerative Colitis.: cross-connection with senolytics: Both converge on the mtDNA–cGAS–STING senescence pathway in pathogenic CD8 T cells — senolytics clear the downstream senescent cells while STING inhibition would block the upstream inflammatory signal. (novelty: 3)
- 2026-07-16 — Age-associated decline of Lamtor5 drives immunosenescence and systemic aging via cGAS-mediated paracrine inflammation.: cross-connection with cgas-targeting-therapeutics: Both intervene on the cGAS–STING axis in aging, but at different nodes: Lamtor5/cGAS interface disruption or macrophage cGAS silencing acts upstream on cytosolic DNA sensing, whereas STING inhibitors (H-151) block the downstream adaptor — the Lamtor5 study provides a mechanistic reason to prefer cell-type-restricted upstream blockade over pan-STING inhibition. (novelty: 3)
- 2026-07-17 — Manganese overload as a previously underappreciated trigger of cellular senescence: Unraveling mechanisms and therapeutic rescue by the senolytic quercetin.: cross-connection with quercetin: Manganese-induced senescence engages STING signaling that quercetin attenuates, linking a natural senolytic to the STING-inhibitor target axis via a shared innate-immune senescence pathway. (novelty: 3)
- 2026-08-18 — Spatial niche remodeling of senescent liver-resident immune cells and its role in chronic liver diseases.: cross-connection with senolytics: Review frames mtDNA–cGAS–STING signaling as a core SASP driver in senescent liver-resident immune cells, positioning STING inhibition as an upstream complement to senolytic clearance in chronic liver disease. (novelty: 3)
- 2026-09-08 — LAPTM5 correlates with RPE senescence and subretinal fibrosis through the LAPTM5-WWP2-OPTN mitophagy cascade and cGAS/STING activation in a D-galactose-induced aging model.: D-galactose-induced aging mouse model: pharmacological STING inhibition with H-151 attenuated RPE epithelial-mesenchymal transition and subretinal fibrosis downstream of a LAPTM5–WWP2–OPTN mitophagy-failure cascade, complementing RPE-specific AAV Laptm5 knockdown (preclinical). [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
LAPTM5 correlates with RPE senescence and subretinal fibrosis through the LAPTM5-WWP2-OPTN mitophagy cascade and cGAS/STING activation in a D-galactose-induced aging model.
08-sep-2026
novelty 3
per-area 3
strengthens